Loading clinical trials...
Loading clinical trials...
Atazanavir (BMS-232632) for HIV Infected Individuals Completing Atazanavir Clinical Trials: An Extended Access Study
Conditions
Interventions
Atazanavir
Atazanavir/Ritonavir
+2 more
Locations
88
United States
Phoenix Body Positive, Inc
Phoenix, Arizona, United States
Rand Schrader Clinic
Los Angeles, California, United States
St Francis Memorial Hospital
San Francisco, California, United States
Sbma Research, Llc
Miami Beach, Florida, United States
St Josephs Cmprhnsv Rsch Inst
Tampa, Florida, United States
Infectious Disease Of Indiana, Psc
Indianapolis, Indiana, United States
Start Date
October 1, 2002
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
May 11, 2017
NCT01875588
NCT06598397
NCT06857071
NCT06627764
NCT07509853
NCT05384145
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions